Source: MarketScreener

4D pharma: TRADING UPDATES: GCP Infra hails NAV rise; Jadestone profits from oil

(marketscreener.com) The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: ---------- 4D Pharma PLC - Leeds-based pharmaceutical firm - Gives update on signal finding study of MRx0518 in combination with anti-PD-1 therapy Keytruda on patients with solid tumours that have progressed on a...https://www.marketscreener.com/quote/stock/4D-PHARMA-PLC-56171591/news/TRADING-UPDATES-GCP-Infra-hails-NAV-rise-Jadestone-profits-from-oil-42892241/?utm_medium=RSS&utm_content=20230203

Read full article »
Annual Revenue
$100K-5.0M
Employees
25-100
Duncan Peyton's photo - CEO of 4D pharma

CEO

Duncan Peyton

CEO Approval Rating

89/100

Read more